Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Saleh M. Alghamd"'
Autor:
Saja H. Almazrou, Ziyad S. Almalki, Abdullah S. Alanazi, Abdulhadi M. Alqahtani, Saleh M. Alghamd
Publikováno v:
Saudi Pharmaceutical Journal, Vol 28, Iss 12, Pp 1877-1882 (2020)
Background: Pharmacological treatments including antivirals (Lopinavir/Ritonavir), Immuno-modulatory and anti-inflammatory drugs including, Tocilizumab and Hydroxychloroquine (HCQ) has been widely investigated as a treatment for COVID-19.Despite the
Externí odkaz:
https://doaj.org/article/0e15e1621fa4406aac734ada793f475d
Autor:
Abdulhadi M. Alqahtani, Abdullah S. Alanazi, Saja Almazrou, Ziyad S. Almalki, Saleh M. Alghamd
Publikováno v:
Saudi Pharmaceutical Journal
Saudi Pharmaceutical Journal : SPJ
Saudi Pharmaceutical Journal, Vol 28, Iss 12, Pp 1877-1882 (2020)
Saudi Pharmaceutical Journal : SPJ
Saudi Pharmaceutical Journal, Vol 28, Iss 12, Pp 1877-1882 (2020)
Background Pharmacological treatments including antivirals (Lopinavir/Ritonavir), Immuno-modulatory and anti-inflammatory drugs including, Tocilizumab and Hydroxychloroquine (HCQ) has been widely investigated as a treatment for COVID-19. Despite the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d56bd88836034fa1e9af9f4f0fb5fb6c
https://doi.org/10.1016/j.jsps.2020.09.019
https://doi.org/10.1016/j.jsps.2020.09.019
Autor:
Khalid Alghamdi, Zeyad Alehaideb, Ashok Kumar, Hamad Al-Eidi, Sahar S. Alghamdi, Rasha Suliman, Rizwan Ali, Feras Almourfi, Saleh M. Alghamdi, Mohamed Boudjelal, Sabine Matou-Nasri
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
There is no first-line treatment for vitiligo, a skin disease characterized by a lack of melanin produced by the melanocytes, resulting in an urgent demand for new therapeutic drugs capable of stimulating melanocyte functions, including melanogenesis
Externí odkaz:
https://doaj.org/article/8f8bc0b2174e4db5a9f538dfba18f04e